pravastatin has been researched along with niclosamide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
Anantharamaiah, GM; Fogelman, AM; Hama, S; Hough, G; Lehrer, RI; Navab, M; Palgunachari, MN; Ruchala, P; Waring, AJ | 1 |
2 other study(ies) available for pravastatin and niclosamide
Article | Year |
---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins E; Atherosclerosis; Biological Availability; Female; Humans; Inflammation; Lipoproteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Mimicry; Niclosamide; Peptides; Pravastatin; Protein Structure, Secondary | 2009 |